You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 9,205,075


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,205,075 protect, and when does it expire?

Patent 9,205,075 protects MITOSOL and is included in one NDA.

This patent has nine patent family members in five countries.

Summary for Patent: 9,205,075
Title:Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application
Abstract: An apparatus and method for preparing a pharmaceutical for transient application includes a tray having a sealed compartment, a vial of an ophthalmic formulation of mitomycin-C, a diluent carrier containing sterilized water, and a syringe that are all contained together in a single package. The component parts of the apparatus are used together to reconstitute the contents of the vial with the water in the diluent carrier, and then draw the reconstituted drug into the sealed compartment of the tray by a suction force produced by the syringe. In the tray compartment, the reconstituted drug is absorbed in at least one absorbent pad. The absorbent pads may come in multiple shapes and or/sizes. The tray is opened to remove the pad and the absorbed drug from the tray compartment for use of the pad in transient application of the drug.
Inventor(s): Timm; Edward J. (Cumming, GA)
Assignee: MOBIUS THERAPEUTICS, LLC (St. Louis, MO)
Application Number:13/445,654
Patent Claim Types:
see list of patent claims
Composition; Formulation; Device;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 9,205,075

Introduction

United States Patent 9,205,075, titled "Apparatus and Method for Preparing a Pharmaceutical and Preparing the Reconstituted Pharmaceutical for Transient Application," is a significant patent in the pharmaceutical field. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

The patent, assigned to Mobius Therapeutics, LLC, was granted on December 8, 2015. It describes an apparatus and method for reconstituting a pharmaceutical and preparing it for transient application. The invention is particularly relevant in the field of pharmaceuticals, where the efficient and safe preparation of medications is crucial.

Scope of the Invention

The scope of the invention encompasses several key aspects:

Apparatus Description

The patent details an apparatus that includes a tray with sealed compartments designed to hold and mix pharmaceutical components. This apparatus is engineered to facilitate the reconstitution of pharmaceuticals in a controlled and sterile environment, ensuring the safety and efficacy of the final product[4].

Method of Preparation

The method involves a series of steps to prepare the pharmaceutical for transient application. This includes the reconstitution of the pharmaceutical components within the sealed compartments, followed by the preparation of the reconstituted pharmaceutical for application. The method emphasizes the importance of maintaining sterility and control throughout the process[4].

Claims Analysis

The patent includes multiple claims that define the scope of the invention. Here are some key claims:

Independent Claims

  • Claim 1 describes the apparatus comprising a tray with sealed compartments, each containing a pharmaceutical component.
  • Claim 10 outlines the method for preparing the pharmaceutical, including the steps of reconstituting and preparing the pharmaceutical for transient application[4].

Dependent Claims

  • These claims further specify the details of the apparatus and method, such as the materials used for the compartments, the mechanism for sealing and mixing, and the specific steps involved in the preparation process[4].

Claim Coverage and Scope Concepts

To understand the value and coverage of these claims, it is essential to analyze them using tools like a Claim Coverage Matrix and scope concepts.

Claim Coverage Matrix

This matrix helps in identifying which patents and claims are actively protecting the intellectual property. For Patent 9,205,075, the matrix would show how the claims cover the specific technology related to pharmaceutical reconstitution and preparation[3].

Scope Concepts

The scope concepts categorize the claims based on overarching ideas that link similar patents. For this patent, scope concepts might include:

  • High-value claims: Those directly related to the core technology of pharmaceutical reconstitution and preparation.
  • Medium-value claims: Those indicating potential future directions, such as adaptations for different types of pharmaceuticals.
  • Low-value claims: Those that may not be as critical to the current technology but could be relevant in future developments[3].

Patent Landscape

The patent landscape surrounding US 9,205,075 involves several key aspects:

Related Patents

The patent is part of a series of related applications and continuations, including U.S. Pat. No. 8,186,511 and U.S. Pat. No. 7,806,265. These patents form a continuum of innovations in the field of pharmaceutical preparation and reconstitution[4].

Field of Classification

The patent is classified under various international and U.S. classifications, such as A61K 31/407 and A61M 35/006, indicating its relevance to pharmaceutical and medical device technologies[4].

Prior Art and References

The patent cites several prior art documents, including U.S. Patent 3,650,393 and U.S. Patent 5,860,806, which highlight the evolutionary nature of the invention within the existing body of knowledge in the field[4].

Economic and Strategic Value

The economic and strategic value of this patent can be significant, given the importance of efficient and safe pharmaceutical preparation methods.

Market Impact

Patents like US 9,205,075 can command substantial value in the market. For instance, the sale of patent portfolios in the pharmaceutical sector can involve millions of dollars, as seen in the sale of Nortel's assets for $4.5 billion[1].

Licensing and Enforcement

The patent's claims and scope can be used to license the technology to other companies or to enforce exclusivity in the market. Effective patent analytics tools can help in tracking and managing these claims to maximize their value[3].

Key Takeaways

  • Invention Scope: The patent covers an apparatus and method for reconstituting and preparing pharmaceuticals for transient application.
  • Claims Analysis: The claims are detailed and specify both the apparatus and the method, with a focus on maintaining sterility and control.
  • Patent Landscape: The patent is part of a broader landscape of related patents and classifications, and it builds upon prior art in the field.
  • Economic Value: The patent holds significant economic and strategic value, particularly in the pharmaceutical industry.

FAQs

  1. What is the primary focus of United States Patent 9,205,075?

    • The primary focus is on an apparatus and method for reconstituting and preparing pharmaceuticals for transient application.
  2. How does the patent ensure the safety and efficacy of the pharmaceutical preparation?

    • The patent ensures safety and efficacy through a controlled and sterile environment provided by the apparatus with sealed compartments.
  3. What is the significance of the claim coverage matrix in patent analytics?

    • The claim coverage matrix helps in identifying which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist.
  4. How does the patent fit into the broader patent landscape?

    • The patent is part of a series of related applications and continuations and is classified under specific international and U.S. classifications.
  5. What is the potential economic value of this patent?

    • The patent can command significant economic value, similar to other high-value patents in the pharmaceutical sector, and can be used for licensing or enforcement.

Sources

  1. Perpetual Motion Patents - The value of a patent.
  2. Administrative Conference of the United States - U.S. Patent Small Claims Court.
  3. Schwegman, Lundberg & Woessner - Patent Analytics.
  4. United States Patent and Trademark Office - US 9,205,075 B2.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,205,075

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Mobius Therap MITOSOL mitomycin FOR SOLUTION;TOPICAL 022572-001 Feb 7, 2012 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,205,075

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2007272514 ⤷  Subscribe
Canada 2659314 ⤷  Subscribe
European Patent Office 2046653 ⤷  Subscribe
European Patent Office 3175843 ⤷  Subscribe
Japan 2009543608 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.